Profile
Full Name
Vir Biotechnology, Inc.Ticker Symbol
VIRExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 11, 2019Indexes
Not includedWebsite
http://www.vir.bioEmployees
408Key Details
Price
$6.12(-2.70%)
Market cap
$839.32M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$63.71M(+61.32% YoY)
Annual EPS
-$3.83(+16.56% YoY)
PE ratio
-
Next earnings date
May 2, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Vir Biotechnology doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 17, 25 Goldman Sachs
BuyFeb 28, 25 HC Wainwright & Co.
BuyFeb 28, 25 Barclays
OverweightFeb 27, 25 Needham
BuyJan 31, 25 HC Wainwright & Co.
BuyJan 13, 25 Leerink Partners
OutperformJan 10, 25 HC Wainwright & Co.
BuyJan 9, 25 Morgan Stanley
OverweightJan 9, 25 JP Morgan
NeutralNov 20, 24 Needham
BuyInstitutional Ownership
- What is the ticker symbol for Vir Biotechnology?
- Does Vir Biotechnology pay dividends?
- What sector is Vir Biotechnology in?
- What industry is Vir Biotechnology in?
- What country is Vir Biotechnology based in?
- When did Vir Biotechnology go public?
- Is Vir Biotechnology in the S&P 500?
- Is Vir Biotechnology in the NASDAQ 100?
- Is Vir Biotechnology in the Dow Jones?
- When was Vir Biotechnology's last earnings report?
- When does Vir Biotechnology report earnings?
- Should I buy Vir Biotechnology stock now?
What is the ticker symbol for Vir Biotechnology?
The ticker symbol for Vir Biotechnology is NASDAQ:VIR
Does Vir Biotechnology pay dividends?
No, Vir Biotechnology does not pay dividends
What sector is Vir Biotechnology in?
Vir Biotechnology is in the Healthcare sector
What industry is Vir Biotechnology in?
Vir Biotechnology is in the Biotechnology industry
What country is Vir Biotechnology based in?
Vir Biotechnology is headquartered in United States
When did Vir Biotechnology go public?
Vir Biotechnology's initial public offering (IPO) was on October 11, 2019
Is Vir Biotechnology in the S&P 500?
No, Vir Biotechnology is not included in the S&P 500 index
Is Vir Biotechnology in the NASDAQ 100?
No, Vir Biotechnology is not included in the NASDAQ 100 index
Is Vir Biotechnology in the Dow Jones?
No, Vir Biotechnology is not included in the Dow Jones index
When was Vir Biotechnology's last earnings report?
Vir Biotechnology's most recent earnings report was on Feb 26, 2025
When does Vir Biotechnology report earnings?
The next expected earnings date for Vir Biotechnology is May 2, 2025
Should I buy Vir Biotechnology stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions